Tag: Rivastigmine

June 9, 2026 / Mohammed looti

Rivastigmine: Restoring Cognitive Function in Dementia

Rivastigmine: An Overview of its Therapeutic Role in Neurodegenerative Disorders Introduction: Unveiling Rivastigmine Rivastigmine is a pharmaceutical agent primarily utilized for the symptomatic treatment of mild to moderate stages of Alzheimer’s disease and mild to moderate Parkinson’s disease dementia. As an acetylcholinesterase inhibitor, its fundamental mechanism involves enhancing cholinergic neurotransmission within the brain. This enhancement […]

Read More
November 20, 2025 / Mohammed looti

EXELON

Introduction and Nomenclature The medication commonly known by the trade name EXELON is formally identified as the active pharmaceutical ingredient rivastigmine, a compound developed for the symptomatic treatment of neurocognitive disorders. Specifically, Exelon is indicated for the management of mild to moderate dementia associated with Alzheimer’s disease (AD) and, in certain clinical settings, mild to […]

Read More